The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-[2-(2-Hydroxy-3-phenoxy-propylamino)-2-methyl-propyl]-2-phenyl-acetamide hydrate ID: ALA3392264
PubChem CID: 118725272
Max Phase: Preclinical
Molecular Formula: C21H30N2O4
Molecular Weight: 356.47
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: CC(C)(CNC(=O)Cc1ccccc1)NCC(O)COc1ccccc1.O
Standard InChI: InChI=1S/C21H28N2O3.H2O/c1-21(2,16-22-20(25)13-17-9-5-3-6-10-17)23-14-18(24)15-26-19-11-7-4-8-12-19;/h3-12,18,23-24H,13-16H2,1-2H3,(H,22,25);1H2
Standard InChI Key: ZUTXCJWTCCZIOT-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 27 0 0 0 0 0 0 0 0999 V2000
5.1796 0.0000 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.3465 2.0466 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.6320 1.6341 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.7969 -0.0159 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.0824 0.3966 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.0610 1.6341 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.3465 2.8716 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2259 -2.4909 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.6320 0.8091 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5114 -1.2534 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7969 -0.8409 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5114 -2.0784 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2259 -3.3159 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.0610 3.2841 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2259 -0.8409 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.4949 1.1111 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3301 -0.3178 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5114 -3.7284 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9403 -3.7284 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.0610 4.1091 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.7754 2.8716 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5114 -4.5534 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.7754 4.5216 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.4899 3.2841 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9403 -4.5534 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2259 -4.9659 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.4899 4.1091 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3 2 1 0
4 5 1 0
5 9 1 0
6 2 2 0
7 2 1 0
8 12 1 0
9 3 1 0
10 11 1 0
11 4 1 0
12 10 1 0
13 8 1 0
14 7 1 0
15 10 1 0
16 5 1 0
17 5 1 0
18 13 1 0
19 13 2 0
20 14 2 0
21 14 1 0
22 18 2 0
23 20 1 0
24 21 2 0
25 19 1 0
26 25 2 0
27 24 1 0
27 23 2 0
26 22 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 356.47Molecular Weight (Monoisotopic): 356.2100AlogP: 2.15#Rotatable Bonds: 10Polar Surface Area: 70.59Molecular Species: BASEHBA: 4HBD: 3#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 8.97CX LogP: 2.37CX LogD: 0.80Aromatic Rings: 2Heavy Atoms: 26QED Weighted: 0.61Np Likeness Score: -0.84
References 1. Lare MS, Smith LH.. (1982) Beta-adrenergic blocking agents. 22. 1-Phenoxy-3-[[(substituted-amido) alkyl]amino]-2-propanols., 25 (11): [PMID:6128420 ] [10.1021/jm00353a004 ]